Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.030 |
None |
1.000 |
3 |
|
2000 |
2005 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.020 |
None |
1.000 |
2 |
|
2000 |
2004 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.020 |
None |
1.000 |
2 |
|
2000 |
2004 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.020 |
None |
1.000 |
2 |
|
2000 |
2001 |
Disseminated Malignant Neoplasm
|
phenotype |
Neoplasms
|
Neoplastic Process
|
232
|
4
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Laryngeal Squamous Cell Carcinoma
|
disease |
Neoplasms; Respiratory Tract Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
504
|
30
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Atrial Fibrillation
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
939
|
584
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Impaired glucose tolerance
|
phenotype |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
596
|
81
|
0.010 |
None |
1.000 |
1 |
1
|
2000 |
2000 |
Low density lipoprotein cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
483
|
1142
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Hematologic Neoplasms
|
group |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
827
|
60
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Secondary malignant neoplasm of liver
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
951
|
34
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Alzheimer Disease, Late Onset
|
disease |
Nervous System Diseases; Mental Disorders
|
Mental or Behavioral Dysfunction
|
385
|
243
|
0.010 |
None |
1.000 |
1 |
1
|
2002 |
2002 |
Chronic atrial fibrillation
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
31
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Adult Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1169
|
66
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Childhood Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1171
|
66
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Serum total cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
486
|
1243
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Tumor Progression
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Neoplastic Process
|
3865
|
72
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Polycystic Ovary Syndrome
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
988
|
363
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Carcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2462
|
103
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Colorectal Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5473
|
1962
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Colorectal Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1296
|
609
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Diabetes
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
2359
|
710
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Diabetes Mellitus
|
group |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
2803
|
824
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Heart failure
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1499
|
201
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |